Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lenormand

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Biochemistry|August 6, 2003
Fidelity and spatio-temporal control in MAP kinase (ERKs) signallingJacques Pouysségur, Philippe Lenormand
Frontiers in Cell and Developmental Biology|July 5, 2016
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?Roser Buscà, Jacques Pouysségur, Philippe Lenormand
Biochemical Pharmacology|September 6, 2002
Fidelity and spatio-temporal control in MAP kinase (ERKs) signallingJacques Pouysségur, Véronique Volmat, Philippe Lenormand
Molecular and Cellular Biology|October 31, 2007
Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levelsRenaud Lefloch, Jacques Pouysségur, Philippe Lenormand
Cell Cycle (Georgetown, Tex.)|February 27, 2009
Total ERK1/2 activity regulates cell proliferationRenaud Lefloch, Jacques Pouysségur, Philippe Lenormand
The Journal of Biological Chemistry|January 4, 2007
Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activityGéraldine Rocher, Claire Letourneux, Philippe Lenormand, et al.
Biochimica Et Biophysica Acta|December 26, 2006
ERK implication in cell cycle regulationJean-Claude Chambard, Renaud Lefloch, Jacques Pouysségur, et al.
Methods (San Diego, Calif.)|August 11, 2025
IF-CRIB: A 3D-printable device to facilitate immunofluorescence experiments and its application in screening and characterizing cells expressing a degradable form of ERK2Elsa Berliocchi, Cercina Onesto, Gilles Pagès, et al.
Oncogene|September 13, 2002
p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanolMarie Knockaert, Philippe Lenormand, Nathanael Gray, et al.
Nucleic Acids Research|July 6, 2023
N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2Roser Buscà, Cercina Onesto, Mylène Egensperger, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Biochemistry|August 6, 2003
Fidelity and spatio-temporal control in MAP kinase (ERKs) signallingJacques Pouysségur, Philippe Lenormand
Frontiers in Cell and Developmental Biology|July 5, 2016
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?Roser Buscà, Jacques Pouysségur, Philippe Lenormand
Biochemical Pharmacology|September 6, 2002
Fidelity and spatio-temporal control in MAP kinase (ERKs) signallingJacques Pouysségur, Véronique Volmat, Philippe Lenormand
Molecular and Cellular Biology|October 31, 2007
Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levelsRenaud Lefloch, Jacques Pouysségur, Philippe Lenormand
Cell Cycle (Georgetown, Tex.)|February 27, 2009
Total ERK1/2 activity regulates cell proliferationRenaud Lefloch, Jacques Pouysségur, Philippe Lenormand
The Journal of Biological Chemistry|January 4, 2007
Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activityGéraldine Rocher, Claire Letourneux, Philippe Lenormand, et al.
Biochimica Et Biophysica Acta|December 26, 2006
ERK implication in cell cycle regulationJean-Claude Chambard, Renaud Lefloch, Jacques Pouysségur, et al.
Methods (San Diego, Calif.)|August 11, 2025
IF-CRIB: A 3D-printable device to facilitate immunofluorescence experiments and its application in screening and characterizing cells expressing a degradable form of ERK2Elsa Berliocchi, Cercina Onesto, Gilles Pagès, et al.
Oncogene|September 13, 2002
p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanolMarie Knockaert, Philippe Lenormand, Nathanael Gray, et al.
Nucleic Acids Research|July 6, 2023
N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2Roser Buscà, Cercina Onesto, Mylène Egensperger, et al.
Pageof 2